% | $
Quotes you view appear here for quick access.

Pharmacyclics, Inc. Message Board

  • mortimer_duke57 mortimer_duke57 Jun 5, 2013 7:18 PM Flag

    Still in and I should still be buying more on the dips. INFI is another classic drug

    Whenever ibrutinib is approved (and hopefully that will be soon), the number of patients taking the medicine will swell. Other oral drugs may quickly follow. We will need to remain vigilant to see if rarer side effects become apparent post approval. And watch for long term surprises.

257.100.00(0.00%)Apr 23 3:59 PMEDT